Evidence map›Paper›PMID 38647987›Full record

ArticleEJNMMI physics2024

Joint EURADOS-EANM initiative for an advanced computational framework for the assessment of external dose rates from nuclear medicine patients.

Lara Struelens, Christelle Huet, David Broggio, Jérémie Dabin, Laurent Desorgher, Augusto Giussani, Wei Bo Li, Dietmar Nosske, Yi-Kang Lee, Lidia Cunha and 3 more

Open access · goldAbstract read
In one paragraph

Article in EJNMMI physics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 6 countries.

Lara StruelensBelgian Nuclear Research Center (SCK CEN), Nuclear Medical Applications, Boeretang 200, 2400, Mol, Belgium. lara.struelens@sckcen.be.ORCID http://orcid.org/0000-0003-4696-9370
Christelle HuetInstitut de Radioprotection et de Sûreté Nucléaire (IRSN), PSE-SANTE/SDOS, 31 Avenue de La Division Leclerc, 92260, Fontenay-Aux-Roses, France.
David BroggioInstitut de Radioprotection et de Sûreté Nucléaire (IRSN), PSE-SANTE/SDOS, 31 Avenue de La Division Leclerc, 92260, Fontenay-Aux-Roses, France.
Jérémie DabinBelgian Nuclear Research Center (SCK CEN), Nuclear Medical Applications, Boeretang 200, 2400, Mol, Belgium.
Laurent DesorgherInstitute of Radiation Physics, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Augusto GiussaniFederal Office for Radiation Protection (BfS), Ingolstädter Landstr. 1, 85764, Oberschleißheim, Germany.
Wei Bo LiFederal Office for Radiation Protection (BfS), Ingolstädter Landstr. 1, 85764, Oberschleißheim, Germany.
Dietmar NosskeFederal Office for Radiation Protection (BfS), Ingolstädter Landstr. 1, 85764, Oberschleißheim, Germany.
Yi-Kang LeeUniversité Paris-Saclay, CEA, Service d'études des réacteurs et de mathématiques appliquées, 91191, Gif-Sur-Yvette, France.
Lidia CunhaNuclear Medicine and Molecular Imaging, IsoPor-Azores, Canada do Breado, 9700, Angra Do Heroismo, Azores, Portugal.
Maria J R CarapinhaESTeSL-Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa, Lisboa, Portugal.
Mario MedvedecDepartment of Nuclear Medicine and Radiation Protection, University Hospital Centre Zagreb, Zagreb, Croatia.
Peter CovensMolecular Imaging and Therapy, Vrije Universiteit Brussel (VUB), Brussels, Belgium.
Federal Office for Radiation Protection · DEBelgian Nuclear Research Centre · BEInstitut de Radioprotection et de Sûreté Nucléaire · FRCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FRHospital de Santo Espirito de Angra do Heroísmo · PTInstituto Politécnico de Lisboa · PTUniversity Hospital Centre Zagreb · HRUniversity of Lausanne · CHVrije Universiteit Brussel · BE

Funding

H2020 Euratom 945196
6 · The paper itself

Abstract

backgroundIn order to ensure adequate radiation protection of critical groups such as staff, caregivers and the general public coming into proximity of nuclear medicine (NM) patients, it is necessary to consider the impact of the radiation emitted by the patients during their stay at the hospital or after leaving the hospital. Current risk assessments are based on ambient dose rate measurements in a single position at a specified distance from the patient and carried out at several time points after administration of the radiopharmaceutical to estimate the whole-body retention. The limitations of such an approach are addressed in this study by developing and validating a more advanced computational dosimetry approach using Monte Carlo (MC) simulations in combination with flexible and realistic computational phantoms and time activity distribution curves from reference biokinetic models.

resultsMeasurements of the ambient dose rate equivalent Ḣ

conclusionsThe validated computational approach will be further used for the evaluation of effective dose rates per unit administered activity for a variety of close-contact configurations and a range of radiopharmaceuticals as part of risk assessment studies. Together with the choice of appropriate dose constraints this would facilitate the setting of release criteria and patient restrictions.

Indexed as

CaregiversComputational modelsMonte CarloNuclear medicine patientsRelease criteria

Identifiers

PMID38647987
PMCPMC11035505
OpenAlexW4395008805

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.